PyroGenesis Canada (PYRGF) Competitors $0.56 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends PYRGF vs. ESPR, SAGE, PROK, CCCC, TSHA, ORGO, MGTX, TKNO, RNAC, and BMEAShould you be buying PyroGenesis Canada stock or one of its competitors? The main competitors of PyroGenesis Canada include Esperion Therapeutics (ESPR), Sage Therapeutics (SAGE), ProKidney (PROK), C4 Therapeutics (CCCC), Taysha Gene Therapies (TSHA), Organogenesis (ORGO), MeiraGTx (MGTX), Alpha Teknova (TKNO), Cartesian Therapeutics (RNAC), and Biomea Fusion (BMEA). These companies are all part of the "pharmaceutical products" industry. PyroGenesis Canada vs. Esperion Therapeutics Sage Therapeutics ProKidney C4 Therapeutics Taysha Gene Therapies Organogenesis MeiraGTx Alpha Teknova Cartesian Therapeutics Biomea Fusion Esperion Therapeutics (NASDAQ:ESPR) and PyroGenesis Canada (NASDAQ:PYRGF) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends, valuation, community ranking and media sentiment. Which has higher earnings & valuation, ESPR or PYRGF? PyroGenesis Canada has lower revenue, but higher earnings than Esperion Therapeutics. PyroGenesis Canada is trading at a lower price-to-earnings ratio than Esperion Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEsperion Therapeutics$116.33M3.42-$209.25M-$0.86-2.36PyroGenesis Canada$9.14M11.24-$21.12M-$0.07-8.00 Do analysts prefer ESPR or PYRGF? Esperion Therapeutics presently has a consensus target price of $8.17, suggesting a potential upside of 302.30%. Given Esperion Therapeutics' higher probable upside, research analysts clearly believe Esperion Therapeutics is more favorable than PyroGenesis Canada.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Esperion Therapeutics 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has more risk & volatility, ESPR or PYRGF? Esperion Therapeutics has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.Comparatively, PyroGenesis Canada has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Does the MarketBeat Community prefer ESPR or PYRGF? Esperion Therapeutics received 612 more outperform votes than PyroGenesis Canada when rated by MarketBeat users. CompanyUnderperformOutperformEsperion TherapeuticsOutperform Votes61269.86% Underperform Votes26430.14% PyroGenesis CanadaN/AN/A Do insiders & institutionals believe in ESPR or PYRGF? 47.4% of Esperion Therapeutics shares are held by institutional investors. Comparatively, 0.0% of PyroGenesis Canada shares are held by institutional investors. 1.0% of Esperion Therapeutics shares are held by company insiders. Comparatively, 47.7% of PyroGenesis Canada shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer ESPR or PYRGF? In the previous week, Esperion Therapeutics had 4 more articles in the media than PyroGenesis Canada. MarketBeat recorded 4 mentions for Esperion Therapeutics and 0 mentions for PyroGenesis Canada. Esperion Therapeutics' average media sentiment score of 0.13 beat PyroGenesis Canada's score of 0.00 indicating that Esperion Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Esperion Therapeutics Neutral PyroGenesis Canada Neutral Is ESPR or PYRGF more profitable? Esperion Therapeutics has a net margin of -35.46% compared to PyroGenesis Canada's net margin of -134.69%. Esperion Therapeutics' return on equity of 0.00% beat PyroGenesis Canada's return on equity.Company Net Margins Return on Equity Return on Assets Esperion Therapeutics-35.46% N/A -15.71% PyroGenesis Canada -134.69%-1,365.53%-62.96% SummaryEsperion Therapeutics beats PyroGenesis Canada on 12 of the 16 factors compared between the two stocks. Ad Timothy SykesHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why Get PyroGenesis Canada News Delivered to You Automatically Sign up to receive the latest news and ratings for PYRGF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PYRGF vs. The Competition Export to ExcelMetricPyroGenesis CanadaPharmaceutical IndustryIndustrial SectorNASDAQ ExchangeMarket Cap$102.77M$7.02B$9.76B$8.53BDividend YieldN/A7.96%2.02%4.14%P/E Ratio-8.009.4720.9915.12Price / Sales11.24381.579.2493.03Price / CashN/A47.3319.4934.05Price / Book-56.005.323.985.02Net Income-$21.12M$153.56M$460.54M$225.46M7 Day Performance-3.45%0.12%-0.14%0.37%1 Month Performance-16.42%15.23%-1.60%3.57%1 Year PerformanceN/A41.16%33.61%29.42% PyroGenesis Canada Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYRGFPyroGenesis CanadaN/A$0.56flatN/AN/A$102.77M$9.14M-8.0090Gap UpESPREsperion Therapeutics4.0444 of 5 stars$2.13+2.4%$8.17+283.4%+136.3%$403.55M$277.79M-2.48240Upcoming EarningsShort Interest ↓News CoverageSAGESage Therapeutics4.3341 of 5 stars$6.44-24.1%$12.29+90.9%-69.3%$387.57M$97.24M-0.87690Earnings ReportAnalyst ForecastAnalyst RevisionHigh Trading VolumePROKProKidney1.4877 of 5 stars$1.68-2.3%$4.50+167.9%-6.9%$385.30MN/A-2.853CCCCC4 Therapeutics2.2199 of 5 stars$5.53-6.3%$10.50+89.9%+325.0%$383.44M$29.38M-2.91150Upcoming EarningsNews CoveragePositive NewsTSHATaysha Gene Therapies1.417 of 5 stars$1.87-0.5%$6.38+240.9%-35.8%$383.24M$12.87M-9.35180News CoverageORGOOrganogenesis4.1493 of 5 stars$2.89-3.0%$4.88+68.7%+21.4%$383.13M$448.39M-22.23950News CoverageMGTXMeiraGTx4.4468 of 5 stars$5.88+0.5%$22.50+282.7%+15.3%$381.61M$8.12M-4.20300High Trading VolumeTKNOAlpha Teknova1.0283 of 5 stars$7.11+0.7%$5.00-29.7%+267.7%$378.98M$34.94M-7.65240Upcoming EarningsNews CoverageRNACCartesian Therapeutics3.3338 of 5 stars$21.14-5.4%$43.00+103.4%N/A$376.21M$54.10M0.0037Positive NewsBMEABiomea Fusion3.8018 of 5 stars$10.34-14.3%$29.60+186.3%-13.5%$374.41MN/A-2.6550Earnings ReportAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies ESPR Alternatives SAGE Alternatives PROK Alternatives CCCC Alternatives TSHA Alternatives ORGO Alternatives MGTX Alternatives TKNO Alternatives RNAC Alternatives BMEA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PYRGF) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PyroGenesis Canada Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PyroGenesis Canada With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
